2023
Emergent external ventricular drain placement in patients with factor Xa inhibitor-associated intracerebral hemorrhage after reversal with andexanet alfa
Ammar A, Elsamadicy A, Ammar M, Reeves B, Koo A, Falcone G, Hwang D, Petersen N, Kim J, Beekman R, Prust M, Magid-Bernstein J, Acosta J, Herbert R, Sheth K, Matouk C, Gilmore E. Emergent external ventricular drain placement in patients with factor Xa inhibitor-associated intracerebral hemorrhage after reversal with andexanet alfa. Clinical Neurology And Neurosurgery 2023, 226: 107621. PMID: 36791588, DOI: 10.1016/j.clineuro.2023.107621.Peer-Reviewed Original ResearchConceptsAndexanet alfaExtra-axial hemorrhageEVD placementThrombotic eventsNew hemorrhagePrimary safety outcomeExternal ventricular drain placementLarge prospective studiesIntensive care unitIntracerebral hemorrhage patientsVentricular drain placementBolus patientsHospital lengthHospital LOSICU LOSTract hemorrhageRankin scoreSecondary outcomesAdult patientsBolus groupPrimary outcomeCare unitIntracerebral hemorrhageLong administration timeHemorrhage patients
2017
Disruption of Brain–Heart Coupling in Sepsis
Admiraal MM, Gilmore EJ, Van Putten MJAM, Zaveri HP, Hirsch LJ, Gaspard N. Disruption of Brain–Heart Coupling in Sepsis. Journal Of Clinical Neurophysiology 2017, 34: 413-420. PMID: 28520632, DOI: 10.1097/wnp.0000000000000381.Peer-Reviewed Original Research
2016
Aneurysmal subarachnoid hemorrhage and severe, catheter-induced vasospasm associated with excessive consumption of a caffeinated energy drink
Grant RA, Cord BJ, Kuzomunhu L, Sheth K, Gilmore E, Matouk CC. Aneurysmal subarachnoid hemorrhage and severe, catheter-induced vasospasm associated with excessive consumption of a caffeinated energy drink. Interventional Neuroradiology 2016, 22: 674-678. PMID: 27481912, PMCID: PMC5564359, DOI: 10.1177/1591019916660868.Peer-Reviewed Original ResearchConceptsCatheter-induced vasospasmAneurysmal subarachnoid hemorrhageSubarachnoid hemorrhageCaffeinated energy drinkExcessive energy drink consumptionSudden cardiac deathAnterior communicating arteryEnergy drinksEnergy drink consumptionExcessive consumptionCoronary vasospasmNeurointerventional literatureEndovascular repairThrombotic complicationsCardiac deathSerious complicationsVasoactive substancesCerebrovascular physiologyCommunicating arteryAlert cliniciansDrink consumptionVasospasmCounter stimulantsComplicationsHemorrhage
2012
Impact of Prolonged Periodic Epileptiform Discharges on Coma Prognosis
Ong C, Gilmore E, Claassen J, Foreman B, Mayer SA. Impact of Prolonged Periodic Epileptiform Discharges on Coma Prognosis. Neurocritical Care 2012, 17: 39-44. PMID: 22700361, DOI: 10.1007/s12028-012-9728-7.Peer-Reviewed Original ResearchConceptsRecovery of consciousnessComatose patientsElectrographic seizuresCEEG monitoringEpileptiform dischargesAdmission Glasgow Coma Scale scoreGlasgow Coma Scale scoreHypoxic-ischemic encephalopathyGlasgow Outcome ScaleTime of dischargeContinuous EEG monitoringNumber of AEDsPeriodic epileptiform dischargesComa prognosisResultsMean ageMedian durationCommon diagnosisIntracerebral hemorrhageFocal hypermetabolismNeuro-ICUSubarachnoid hemorrhageFrequent findingOutcome ScaleClinical significanceLikelihood of survivalAcute Effects of Nimodipine on Cerebral Vasculature and Brain Metabolism in High Grade Subarachnoid Hemorrhage Patients
Choi HA, Ko SB, Chen H, Gilmore E, Carpenter AM, Lee D, Claassen J, Mayer SA, Schmidt JM, Lee K, Connelly ES, Paik M, Badjatia N. Acute Effects of Nimodipine on Cerebral Vasculature and Brain Metabolism in High Grade Subarachnoid Hemorrhage Patients. Neurocritical Care 2012, 16: 363-367. PMID: 22262041, DOI: 10.1007/s12028-012-9670-8.Peer-Reviewed Original ResearchConceptsPoor-grade subarachnoid hemorrhageOral nimodipineSubarachnoid hemorrhageMmHg decreasePoor-grade SAH patientsDoses of nimodipineAdministration of nimodipineAneurysmal subarachnoid hemorrhageSubarachnoid hemorrhage patientsRoutine clinical careAcute PhysiologicAdequate CBFNimodipine administrationOnly medicationHemorrhage patientsMultimodality monitoringSAH patientsVasopressor medicationsBrain metabolismAcute effectsObservational studyMetabolic effectsCerebral vasculatureClinical careNimodipine
2011
Prevention of Shivering During Therapeutic Temperature Modulation: The Columbia Anti-Shivering Protocol
Choi HA, Ko SB, Presciutti M, Fernandez L, Carpenter AM, Lesch C, Gilmore E, Malhotra R, Mayer SA, Lee K, Claassen J, Schmidt JM, Badjatia N. Prevention of Shivering During Therapeutic Temperature Modulation: The Columbia Anti-Shivering Protocol. Neurocritical Care 2011, 14: 389-394. PMID: 21210305, DOI: 10.1007/s12028-010-9474-7.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic alpha-2 Receptor AgonistsAdultAgedAnticonvulsantsConscious SedationCritical CareDexmedetomidineDose-Response Relationship, DrugFemaleFeverGlasgow Coma ScaleHeart ArrestHumansHypothermia, InducedIntensive Care UnitsIntracranial HypertensionMagnesium SulfateMaleMeperidineMiddle AgedMonitoring, PhysiologicNarcoticsNeuromuscular Nondepolarizing AgentsPropofolProspective StudiesShiveringVecuronium BromideConceptsPatient daysNeurological intensive care unitAnti-shivering agentsTherapeutic temperature modulationTotal patient daysPrevention of shiveringDoses of propofolIntensive care unitBaseline demographic informationNew clinical problemsInduced normothermiaMethodsAll patientsYounger patientsCare unitCumulative doseHigh riskClinical problemPatientsTemperature modulating devicesMore interventionsShiveringBaseline interventionDemographic informationFirst agentYoung men